Sino Historical Income Statement
| 688108 Stock | 9.79 0.01 0.10% |
Historical analysis of Sino Medical income statement accounts such as Selling General Administrative of 82.7 M, Total Revenue of 246.2 M or Gross Profit of 190.1 M can show how well Sino Medical Sciences performed in making a profits. Evaluating Sino Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sino Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sino Medical Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sino Medical Sciences is a good buy for the upcoming year.
Sino |
About Sino Income Statement Analysis
Sino Medical Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sino Medical shareholders. The income statement also shows Sino investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sino Medical Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Sino Medical Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Sino Medical Sciences minus its cost of goods sold. It is profit before Sino Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sino Medical Sciences. It is also known as Sino Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Sino Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sino Medical Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Sino Medical's Gross Profit is projected to decrease significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 170.3 M, whereas Tax Provision is projected to grow to (20.9 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Gross Profit | 121.7M | 202.2M | 182.0M | 190.1M | Total Revenue | 192.9M | 343.3M | 308.9M | 246.2M |
Sino Medical income statement Correlations
Click cells to compare fundamentals
Sino Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sino Medical income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 6.3M | (31.8M) | (48.0M) | (24.5M) | (22.0M) | (20.9M) | |
| Net Interest Income | 6.6M | 2.3M | 257.2K | (1.3M) | (1.2M) | (1.1M) | |
| Interest Expense | 5.8M | 2.2M | 2.5M | 3.7M | 4.3M | 2.8M | |
| Selling General Administrative | 96.2M | 83.2M | 83.4M | 94.0M | 84.6M | 82.7M | |
| Total Revenue | 327.4M | 194.4M | 192.9M | 343.3M | 308.9M | 246.2M | |
| Gross Profit | 261.6M | 143.5M | 121.7M | 202.2M | 182.0M | 190.1M | |
| Other Operating Expenses | 3.9M | 1.2M | 612.4K | 5.8M | 5.2M | 3.0M | |
| Operating Income | 13.7M | (156.1M) | (200.0M) | (57.8M) | (52.0M) | (49.4M) | |
| Net Income From Continuing Ops | 22.5M | (131.3M) | (173.3M) | (43.4M) | (39.1M) | (37.1M) | |
| Ebit | 100.1M | 11.9M | (156.1M) | (200.0M) | (180.0M) | (171.0M) | |
| Research Development | 108.7M | 148.9M | 152.8M | 114.1M | 131.2M | 111.4M | |
| Cost Of Revenue | 65.8M | 50.9M | 71.1M | 141.0M | 162.2M | 170.3M | |
| Total Operating Expenses | 313.8M | 350.4M | 392.9M | 401.1M | 461.2M | 348.6M | |
| Income Before Tax | 28.8M | (163.1M) | (221.3M) | (67.9M) | (61.1M) | (58.0M) | |
| Net Income Applicable To Common Shares | 90.0M | 22.5M | (130.8M) | (162.4M) | (146.1M) | (138.8M) | |
| Net Income | 22.5M | (130.8M) | (162.4M) | (39.6M) | (35.7M) | (33.9M) | |
| Income Tax Expense | 17.9M | 6.3M | (31.8M) | (48.0M) | (43.2M) | (41.1M) | |
| Interest Income | 6.7M | 4.7M | 3.0M | 2.6M | 3.0M | 4.0M | |
| Ebitda | 131.2M | 61.4M | (95.5M) | (155.6M) | (140.1M) | (133.1M) | |
| Reconciled Depreciation | 38.3M | 65.4M | 63.2M | 62.8M | 72.2M | 46.5M |
Currently Active Assets on Macroaxis
Other Information on Investing in Sino Stock
Sino Medical Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sino Medical shareholders. The income statement also shows Sino investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).